Journal of Thyroid Research最新文献

{"title":"Prevalence and Associations of Hypothyroidism in Indian Patients with Type 2 Diabetes Mellitus.","authors":"Abilash Nair,&nbsp;C Jayakumari,&nbsp;P K Jabbar,&nbsp;R V Jayakumar,&nbsp;Nishant Raizada,&nbsp;Anjana Gopi,&nbsp;Geena Susan George,&nbsp;T P Seena","doi":"10.1155/2018/5386129","DOIUrl":"https://doi.org/10.1155/2018/5386129","url":null,"abstract":"<p><p>Both type 2 diabetes and hypothyroidism are highly prevalent disorders in the community. The existing data regarding prevalence of hypothyroidism in patients with diabetes comes mostly from small studies. There are only two studies with a sample size of more than 1000 diabetic patients, none of which have been done in South Asians. The present study evaluated patients with type 2 diabetes for presence of hypothyroidism and the clinical factors associated with it. The demographic, anthropometric, clinical, and biochemical parameters of consecutively enrolled patients with diabetes were systematically collected and analyzed. A total of 1152 middle aged patients with type 2 diabetes with a mean duration of diabetes of around 10 years were enrolled. Nearly 40 percent of the patients were obese and overweight, respectively, for South Asian standards and abdominal obesity was seen in around 90% patients. Clinical hypothyroidism (TSH>10 mIU/ml) was present in 113 of patients (9.83%) and another 68 patients (5.9%) had subclinical hypothyroidism (TSH 5-10 mIU/ml). Anemia (odds ratio : 2.19), overweight/obese status (odds ratio 2.07), and known dyslipidemia (odds ratio : 1.99) were found to have independent association with clinical hypothyroidism. HbA1c, abdominal obesity, poor control of hypertension, lipid parameters, microalbuminuria, and renal dysfunction showed no difference among patients with hypothyroidism when compared with euthyroid patients. Subclinical hypothyroid patients had no difference in any of the above analyzed parameters when compared to the euthyroid patients. This study shows that a significant proportion of type 2 diabetes patients suffer from clinical or subclinical hypothyroidism and screening for the same may be appropriate.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"5386129"},"PeriodicalIF":2.1,"publicationDate":"2018-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/5386129","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36455711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Short Stay Thyroid Surgery: Can We Replicate the Same in Low Resource Setting?","authors":"Naval Bansal,&nbsp;Sanjay Kumar Yadav,&nbsp;Saroj Kanta Mishra,&nbsp;Kamal Kishore,&nbsp;Anjali Mishra,&nbsp;Gyan Chand,&nbsp;Gaurav Agarwal,&nbsp;Amit Agarwal,&nbsp;Ashok Kumar Verma","doi":"10.1155/2018/4910961","DOIUrl":"https://doi.org/10.1155/2018/4910961","url":null,"abstract":"<p><strong>Introduction: </strong>The concept of short stay thyroidectomy has been tested and in practice in the developed world; the same has not been replicated in countries with limited resources due to lack of organized healthcare system. So, in this study, we tried to analyze if short stay thyroid surgery can be performed in a cost-effective way in developing countries and also if the endocrine surgical trainee can deliver these services safely.</p><p><strong>Methods: </strong>The study was conducted prospectively from January 2013 to July 2014, at Department of Endocrine Surgery, SGPGIMS, Lucknow, India. Study group included patients undergoing short stay hemithyroidectomy whereas matched patients who qualified for inclusion criteria but did not undergo short stay surgery due to various reasons constituted control group. Outcome in both the groups was compared in terms of complication rates, cost benefit, and patient satisfaction. Subgroup analysis was also done for trainee versus consultant performed short stay thyroid surgery.</p><p><strong>Results: </strong>A total of 439 patients with surgical thyroid disorders were evaluated at our institute during the study period and out of these 110 patients (58 cases and 52 controls) fulfilled the inclusion criteria. Younger patients with low socioeconomic status who were paying out of pocket were found to be more inclined to short stay thyroid surgery. There was no significant difference between the two groups in terms of postanesthetic discharge score (PADS), complication rates, and patients satisfaction; however there was significant reduction (p <0.001) in hospital cost in short stay group. In subgroup analysis, procedure time was more in trainee performed surgeries; however there was no significant difference in terms of mean PADS and complication rates.</p><p><strong>Conclusion: </strong>Short stay thyroidectomy can provide a better cost-effective alternative to conventional thyroidectomy in patients undergoing thyroid surgery and can be safely performed by endocrine surgical trainees even in a low resource setting.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"4910961"},"PeriodicalIF":2.1,"publicationDate":"2018-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/4910961","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36436344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association.","authors":"Valmore Bermúdez, Juan Salazar, Roberto Añez, Milagros Rojas, Viviana Estrella, María Ordoñez, Maricarmen Chacín, Juan Diego Hernández, Víctor Arias, Mayela Cabrera, Clímaco Cano-Ponce, Joselyn Rojas","doi":"10.1155/2018/8251076","DOIUrl":"10.1155/2018/8251076","url":null,"abstract":"<p><strong>Introduction: </strong>Subclinical hypothyroidism (ScH) is an endocrine alteration that is related to cardiovascular risk factors, including those categorized as components of the Metabolic Syndrome (MS). However, findings in prior reports regarding an association between these alterations are inconsistent. The purpose of this study was to determine the relationship between both entities in adult subjects from Maracaibo City, Venezuela.</p><p><strong>Materials and methods: </strong>The Maracaibo City Metabolic Syndrome Prevalence Study is a descriptive, cross-sectional study with random and multistage sampling. In this substudy, 391 individuals of both genders were selected and TSH, free T3, and free T4 tests were performed as well as a complete lipid profile, fasting glycaemia, and insulin blood values. ScH was defined according to the National Health and Nutrition Examination Survey (NHANES) criteria: high TSH (≥4.12mUI/L) and normal free T4 (0.9-1,9 ng/dL) in subjects without personal history of thyroid disease. MS components were defined according to IDF/AHA/NHLBI/WHF/IAS/IASO-2009 criteria. A multiple logistic regression analysis was used to assess the relationship between MS components and ScH diagnosis.</p><p><strong>Results: </strong>Of the evaluated population, 10.5% (n=41) was diagnosed with ScH, with a higher prevalence in women (female: 13.6% versus male: 7.7%; <i>χ</i>2=3.56, p=0.05). Likewise, 56.1% (n=23) of the subjects with ScH were diagnosed with MS (<i>χ</i>2=4.85; p=0.03), being hyperglycemia the main associated criterion (<i>χ</i>2=11.7; p=0.001). In multivariable analysis, it was observed that the relationship was exclusive with the presence of type 2 diabetes mellitus (T2DM) OR: 3.22 (1.14-9.14); p=0.03.</p><p><strong>Conclusion: </strong>The relationship between ScH and MS in our population is dependent on the presence of hyperglycemia, specifically T2DM diagnosis, findings that vary from those previously reported in Latin American subjects.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"8251076"},"PeriodicalIF":2.1,"publicationDate":"2018-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087593/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36434728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lessons from Randomised Clinical Trials for Triiodothyronine Treatment of Hypothyroidism: Have They Achieved Their Objectives?","authors":"Rudolf Hoermann,&nbsp;John E M Midgley,&nbsp;Rolf Larisch,&nbsp;Johannes W Dietrich","doi":"10.1155/2018/3239197","DOIUrl":"https://doi.org/10.1155/2018/3239197","url":null,"abstract":"<p><p>Randomised controlled trials are deemed to be the strongest class of evidence in evidence-based medicine. Failure of trials to prove superiority of T3/T4 combination therapy over standard LT4 monotherapy has greatly influenced guidelines, while not resolving the ongoing debate. Novel studies have recently produced more evidence from the examination of homeostatic equilibria in humans and experimental treatment protocols in animals. This has exacerbated a serious disagreement with evidence from the clinical trials. We contrasted the weight of statistical evidence against strong physiological counterarguments. Revisiting this controversy, we identify areas of improvement for trial design related to validation and sensitivity of QoL instruments, patient selection, statistical power, collider stratification bias, and response heterogeneity to treatment. Given the high individuality expressed by thyroid hormones, their interrelationships, and shifted comfort zones, the response to LT4 treatment produces a statistical amalgamation bias (Simpson's paradox), which has a key influence on interpretation. In addition to drug efficacy, as tested by RCTs, efficiency in clinical practice and safety profiles requires reevaluation. Accordingly, results from RCTs remain ambiguous and should therefore not prevail over physiologically based counterarguments. In giving more weight to other forms of valid evidence which contradict key assumptions of historic trials, current treatment options should remain open and rely on personalised biochemical treatment targets. Optimal treatment choices should be guided by strict requirements of organizations such as the FDA, demanding treatment effects to be estimated under actual conditions of use. Various improvements in design and analysis are recommended for future randomised controlled T3/T4 combination trials.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"3239197"},"PeriodicalIF":2.1,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/3239197","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36455710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence of Second Malignancy in Patients with Papillary Thyroid Cancer from Surveillance, Epidemiology, and End Results 13 Dataset.","authors":"Mayumi Endo,&nbsp;Jessica B Liu,&nbsp;Marcelle Dougan,&nbsp;Jennifer S Lee","doi":"10.1155/2018/8765369","DOIUrl":"https://doi.org/10.1155/2018/8765369","url":null,"abstract":"<p><p>Increased risk of second primary malignancy (SPM) in papillary thyroid cancer (PTC) has been reported. Here, we present the most updated incidence rates of second primary malignancy from original diagnosis of PTC by using the data from the Surveillance, Epidemiology, and End Results. In this cohort, 3,200 patients developed SPM, a substantially higher number than in the reference population of 2,749 with observed to expected ratio (O/E) of 1.16 (95% CI; 1.12-1.21). Bone and joint cancer had the highest O/E ratio of 4.26 (95% confidence interval [CI] 2.33-7.15) followed by salivary gland (O/E 4.15; 95% CI 2.76-6.0) and acute lymphocytic leukemia (O/E 3.98; 95% CI 2.12-6.8). Mean age at the diagnosis of SPM was 64.4 years old. Interestingly, incidence of colorectal cancer was lower in thyroid cancer survivors compared to general population (large intestine O/E 0.3; 95% CI 0.06-0.88, rectum O/E 0.6; 95% CI 0.41-0.85); however, this was not observed in patients who underwent radiation therapy. The incidence of SPM at all sites was higher during 2000-2012 compared to 1992-1999 (O/E 1.24 versus 1.10). Surprisingly, patients with micropapillary cancer had higher incidence of SPM than counterparts with a larger tumor in radiation group (O/E of 1.40 versus 1.15). O/E of all cancers were higher in males compared to females with O/E of 1.41 versus 1.17 during the period of 2000-2012. Diagnosis of PTC before age 50, especially at age 30-34, was associated with higher incidence of overall SPM (age 30-34; O/E 1.43; 95% CI; 1.19-1.71). Efficient monitoring strategies that include age at the time of thyroid cancer diagnosis, exposure to radiation, gender, and genetic susceptibility may successfully detect SPM earlier in the disease course. This is especially important given the excellent prognosis of the initial thyroid cancer itself.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"8765369"},"PeriodicalIF":2.1,"publicationDate":"2018-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/8765369","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36342172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Spontaneous Slowing and Regressing of Tumor Growth in Childhood/Adolescent Papillary Thyroid Carcinomas Suggested by the Postoperative Thyroglobulin-Doubling Time.","authors":"Toshihiko Kasahara,&nbsp;Akira Miyauchi,&nbsp;Takumi Kudo,&nbsp;Eijun Nishihara,&nbsp;Mitsuru Ito,&nbsp;Yasuhiro Ito,&nbsp;Minoru Kihara,&nbsp;Akihiro Miya","doi":"10.1155/2018/6470251","DOIUrl":"https://doi.org/10.1155/2018/6470251","url":null,"abstract":"<p><strong>Background: </strong>Children and adolescents with papillary thyroid carcinomas (PTCs) have generally excellent prognoses despite their frequent extended disease. The tumor growth of young patients' PTCs might show spontaneous slowing postoperatively. We compared young PTC patients' postoperative thyroglobulin-doubling time (Tg-DT) with their preoperative hypothetical tumor volume-doubling time (hTV-DT).</p><p><strong>Methods: </strong>Fourteen PTC patients aged ≤18 years who underwent total thyroidectomy at Kuma Hospital in 1998-2016 had biochemically persistent disease postoperatively. We calculated their Tg-DTs and estimated their preoperative TV-DTs with the tumor size and the patient's age at surgery, presuming that a single cancer cell was present at the patient's birth.</p><p><strong>Results: </strong>Twelve patients had positive Tg-DTs ranging from 2.0 to 147 years, and the remaining two had negative Tg-DTs, indicating slow growth or even regression. The hTV-DTs were 0.3-0.6 years (median 0.5 years), which were significantly shorter than the Tg-DTs (<i>p</i> < 0.001), indicating much faster growth preoperatively. The analyses of the nine patients without radioactive iodine administration (RAI) gave similar results (<i>p</i> < 0.01).</p><p><strong>Conclusions: </strong>Irrespective of RAI, the patients' postoperative Tg-DTs were significantly longer than their preoperative hTV-DTs and were negative values in two patients, indicating that the growth of these young patients' PTCs had spontaneously slowed or even regressed postoperatively.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"6470251"},"PeriodicalIF":2.1,"publicationDate":"2018-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/6470251","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36189333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Outcome of Papillary Thyroid Cancer Associated with Graves' Disease: A Case Control Study.","authors":"Riju Menon, C Gopalakrishnan Nair, Misha Babu, Pradeep Jacob, G Praveen Krishna","doi":"10.1155/2018/8253094","DOIUrl":"10.1155/2018/8253094","url":null,"abstract":"<p><strong>Introduction: </strong>Thyroidectomy is now a less popular therapeutic option for Graves' disease. The frequency of thyroid nodule and the cancer risk of these nodules accompanying Graves' disease are controversial. The outcome of thyroid cancers coexisting with Graves' disease is debated.</p><p><strong>Study design: </strong>Designed as retrospective case control study of papillary thyroid cancers associated with Graves' disease and those with euthyroid background. Pathological characteristics and outcome of papillary thyroid cancers in the two groups were compared.</p><p><strong>Results: </strong>The tumour characteristics did not differ significantly in the groups. The patients were followed for a mean period of 77.32 months and found significant incidences of disease progression in patients with papillary thyroid cancer associated with Graves' disease (<i>p</i> = 0.034; OR 2.747, CI 1.078-7.004). Disease progression as new distant metastases mostly in skeletal locations was high in this group compared to euthyroid group (<i>p</i> = 0.027; OR 4.121, CI 1.008-15.600). There was higher incidence of cumulative metastatic diseases in papillary thyroid cancer associated with Graves' disease.</p><p><strong>Conclusion: </strong>Papillary thyroid cancers associated with Graves' disease show aggressive biological behaviour and favoured site of distant metastases was osseous locations. Early diagnosis by routine screening of Graves' disease patients with ultrasound imaging and aspiration studies is recommended.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"8253094"},"PeriodicalIF":2.1,"publicationDate":"2018-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36182570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnostic Accuracy of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Detecting Occult Papillary Thyroid Microcarcinomas in Benign Multinodular Goitres.","authors":"Dimitrios K Manatakis,&nbsp;Sophia Tseleni-Balafouta,&nbsp;Lazaros Tzelves,&nbsp;Dimitrios Balalis,&nbsp;Adelais Tzortzopoulou,&nbsp;Dimitrios P Korkolis,&nbsp;George H Sakorafas,&nbsp;Emmanouil Gontikakis,&nbsp;Georgios Plataniotis","doi":"10.1155/2018/3470429","DOIUrl":"https://doi.org/10.1155/2018/3470429","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the diagnostic accuracy of neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios in detecting occult papillary thyroid microcarcinomas in benign, multinodular goitres.</p><p><strong>Methods: </strong>397 total thyroidectomy patients were identified from the institutional thyroid surgery database between 2007 and 2016 (94 males, 303 females, mean age 53 ± 14.5 years). NLR and PLR were calculated as the absolute neutrophil and absolute platelet counts divided by the absolute lymphocyte count, respectively, based on the preoperative complete blood cell count.</p><p><strong>Results: </strong>NLR was significantly higher in carcinomas and microcarcinomas compared to benign pathology (<i>p</i> = 0.026), whereas a direct association could not be established for PLR. Both NLR and PLR scored low in all parameters of diagnostic accuracy, with overall accuracy ranging between 45 and 50%.</p><p><strong>Conclusions: </strong>As surrogate indices of the systemic inflammatory response, NLR and PLR are inexpensive and universally available from routine blood tests. Although we found higher NLR values in cases of malignancy, NLR and PLR cannot effectively predict the presence of occult papillary microcarcinomas in otherwise benign, multinodular goitres.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"3470429"},"PeriodicalIF":2.1,"publicationDate":"2018-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/3470429","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36178590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Significance of Testing Anti-Thyroid Autoantibodies in Patients with Deranged Thyroid Profile.","authors":"Hamid Nawaz Tipu,&nbsp;Dawood Ahmed,&nbsp;Muhammad Mukarram Bashir,&nbsp;Naveed Asif","doi":"10.1155/2018/9610497","DOIUrl":"https://doi.org/10.1155/2018/9610497","url":null,"abstract":"<p><strong>Background: </strong>We hypothesized that anti-thyroid antibodies are more often positive in individuals with deranged thyroid profile.</p><p><strong>Methods: </strong>This prospective cohort was done in Immunology Department, Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from Jan 2017 to Oct 2017. All the samples that were referred to us for testing anti-thyroid antibodies (anti-TPO or anti-TG antibodies) and thyroid profile were included in the study. There were no exclusion criteria. Tests for anti-thyroid antibodies were performed by ELISA and thyroid profile by chemiluminescence. SPSS 23.0 was used for statistical analysis.</p><p><strong>Results: </strong>Over a course of a ten-month study period, we received a total of 316 serum samples for anti-TPO/TG antibodies along with thyroid profile testing (TSH). These included 115 males (36.4%) and 201 females (63.6%). Their age ranged from 3 to 89 years (mean ± SD, 42.22 ± 18.09). Anti-TPO antibodies were more often positive when TSH was deranged (<i>p</i> value 0.001). Anti-TPO antibodies are more often raised in females, in terms of both prevalence (<i>p</i> 0.001) and mean rank (<i>p</i> 0.002).</p><p><strong>Conclusion: </strong>As anti-thyroid antibodies are more often present when TSH is deranged, such individuals should be screened for anti-thyroid antibodies. This importance of screening is compounded by the fact that anti-thyroid antibodies may be positive in a significant percentage of elderly people.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"9610497"},"PeriodicalIF":2.1,"publicationDate":"2018-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/9610497","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36178591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cytomorphological Spectrum of Thyroiditis: A Review of 110 Cases.","authors":"Shirish S Chandanwale, Rahul Nair, Anushree Gambhir, Supreet Kaur, Aditi Pandey, Abhinav Shetty, Piyusha Naragude","doi":"10.1155/2018/5246516","DOIUrl":"10.1155/2018/5246516","url":null,"abstract":"<p><strong>Introduction: </strong>Different types of thyroiditis may share some parallel clinical and biochemical features. Timely intervention can significantly reduce morbidity and mortality.</p><p><strong>Aim: </strong>Aim of this study is to find the frequency of various thyroiditis, study the cytomorphological features and correlate with clinical findings including radiological findings, thyroid function test, and anti-thyroid peroxidase antibodies (Anti-TPO antibodies).</p><p><strong>Materials and methods: </strong>The study included consecutive 110 cases of thyroiditis. Detailed cytomorphological features were studied and correlated with ultrasonography findings, thyroid function test, anti-thyroid peroxidase antibodies (anti-TPO) and histopathological features where thyroidectomy specimens were received for histopathological examination.</p><p><strong>Results: </strong>The majority were Hashimoto's thyroiditis (<i>n</i> = 100) and females (<i>n</i> = 103). Other forms of thyroiditis were Hashimoto's thyroiditis with colloid goiter (<i>n</i> = 5), De Quervain's thyroiditis (<i>n</i> = 3), and one case each of postpartum thyroiditis and Hashimoto's thyroiditis with associated malignancy. The majority of patients were in the age group of 21-40 (<i>n</i> = 70) and the majority (<i>n</i> = 73) had diffuse enlargement of thyroid. The majority of patients were hypothyroid (<i>n</i> = 52). The serum anti-TPO antibodies were elevated in 47 patients out of 71 patients. In the 48 patients who underwent ultrasonography, 38 were diagnosed as having thyroiditis. The most consistent cytomorphological features seen in fine-needle aspiration smears of Hashimoto's thyroiditis were increased background lymphocytes, lymphocytic infiltration of thyroid follicular cell clusters, and Hurthle cells.</p><p><strong>Conclusion: </strong>The diagnostic cytological features in Hashimoto's thyroiditis are increased background lymphocytes, lymphocytic infiltration of thyroid follicular cell clusters, and Hurthle cells. FNAC remains the \"Gold Standard\" for diagnosing Hashimoto's thyroiditis. Clinical history, thyroid function, and biochemical parameters are the key for diagnosis of other forms of thyroiditis.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2018 ","pages":"5246516"},"PeriodicalIF":2.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36036907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}